{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:27:15Z","timestamp":1790659635910,"version":"4.1.0"},"reference-count":88,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Asthma is generally characterized by variable symptoms such as dyspnea and wheezing and variable airflow obstruction. This review focuses on a subset of patients suffering from asthma with persistent airflow limitation that is not fully reversible (asthma with fixed airflow obstruction, FAO). The pathophysiology, the risk factors and the clinical outcomes associated with FAO are presented, as well as the distinct clinical entity of severe asthma and its inflammatory subtypes (T2 and non-T2). The current strategies for the treatment of these endotypes and treatment of the distinct Asthma\/COPD overlap (ACO) phenotype are described. Management and medical interventions in FAO and\/or ACO patients demand a holistic approach, which is not yet clearly established in guidelines worldwide. Finally, a treatment algorithm that includes FAO\/ACO management based on pharmacological and non-pharmacological treatment, guideline-based management for specific co-morbidities, and modification of the risk factors is proposed.<\/jats:p>","DOI":"10.3390\/jpm12030333","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T22:54:02Z","timestamp":1645656842000},"page":"333","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-6800","authenticated-orcid":false,"given":"Agamemnon","family":"Bakakos","sequence":"first","affiliation":[{"name":"1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-2611","authenticated-orcid":false,"given":"Stamatina","family":"Vogli","sequence":"additional","affiliation":[{"name":"5th Pulmonary Department, \u2018Sotiria\u2019 Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dimakou","sequence":"additional","affiliation":[{"name":"5th Pulmonary Department, \u2018Sotiria\u2019 Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Hillas","sequence":"additional","affiliation":[{"name":"5th Pulmonary Department, \u2018Sotiria\u2019 Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"ref_1","unstructured":"Global Initiative for Asthma (2021, November 08). Global Strategy for Asthma Management and Prevention. Available online: http:\/\/www.ginasthma.org."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1378\/chest.126.1.59","article-title":"Asthma as a risk factor for COPD in a longitudinal study","volume":"126","author":"Silva","year":"2004","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kendzerska, T., Sadatsafavi, M., Aaron, S.D., To, T.M., Lougheed, M.D., FitzGerald, J.M., and Gershon, A.S. (2017). Canadian Respiratory Research, N., Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173830"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.alit.2018.02.002","article-title":"Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO)","volume":"67","author":"Uchida","year":"2018","journal-title":"Allergol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/02770903.2016.1247168","article-title":"Coexisting COPD in elderly asthma with fixed airflow limitation: Assessment by DLco% predicted and HRCT","volume":"54","author":"Tamada","year":"2017","journal-title":"J. Asthma"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1164\/ajrccm.152.3.7663797","article-title":"Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction","volume":"152","author":"Boulet","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/ajrccm.150.4.7921469","article-title":"Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study","volume":"150","author":"Kanner","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2004400","DOI":"10.1183\/13993003.04400-2020","article-title":"Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction","volume":"58","author":"Durack","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_9","first-page":"296","article-title":"Prevalence of small airways dysfunction in asthma with- and without-fixed airflow obstruction and chronic obstructive pulmonary disease","volume":"39","author":"Pornsuriyasak","year":"2021","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"ref_10","unstructured":"Cottee, A.M., Seccombe, L.M., Thamrin, C., King, G.G., Peters, M.J., and Farah, C.S. (2021). Oscillometry and asthma control in patients with and without fixed airflow obstruction. J. Allergy Clin. Immunol. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/archinte.160.11.1683","article-title":"Obstructive lung disease and low lung function in adults in the United States: Data from the National Health and Nutrition Examination Survey, 1988\u20131994","volume":"160","author":"Mannino","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.rmed.2008.04.011","article-title":"The course of persistent airflow limitation in subjects with and without asthma","volume":"102","author":"Guerra","year":"2008","journal-title":"Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1164\/ajrccm.164.supplement_2.2106061","article-title":"Remodeling in asthma and chronic obstructive lung disease","volume":"164","author":"Jeffery","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0091-6749(99)70225-3","article-title":"Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis","volume":"103","author":"Vignola","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.00117013","article-title":"Disconnect between sputum neutrophils and other measures of airway inflammation in asthma","volume":"43","author":"Arron","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1378\/chest.07-1047","article-title":"Association between neutrophilic airway inflammation and airflow limitation in adults with asthma","volume":"132","author":"Shaw","year":"2007","journal-title":"Chest"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm.164.5.2011026","article-title":"Factors associated with persistent airflow limitation in severe asthma","volume":"164","author":"Zwinderman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1164\/rccm.200203-183OC","article-title":"Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease","volume":"167","author":"Fabbri","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmed.2020.00191","article-title":"Airway Remodeling in Asthma","volume":"7","author":"Hough","year":"2020","journal-title":"Front. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/all.14691","article-title":"Correlation of matrix-related airway remodeling and bradykinin B1 receptor expression with fixed airflow obstruction in severe asthma","volume":"76","author":"Bertolini","year":"2021","journal-title":"Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.chest.2017.11.016","article-title":"Further Studies of Unsuspected Emphysema in Nonsmoking Patients with Asthma with Persistent Expiratory Airflow Obstruction","volume":"153","author":"Gelb","year":"2018","journal-title":"Chest"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1378\/chest.121.3.715","article-title":"Unsuspected loss of lung elastic recoil in chronic persistent asthma","volume":"121","author":"Gelb","year":"2002","journal-title":"Chest"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/resp.13688","article-title":"Reduced lung elastic recoil and fixed airflow obstruction in asthma","volume":"25","author":"Tonga","year":"2020","journal-title":"Respirology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200609-1317OC","article-title":"Airway distensibility in adults with asthma and healthy adults, measured by forced oscillation technique","volume":"176","author":"Brown","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Shimizu, K., Tanabe, N., Oguma, A., Kimura, H., Suzuki, M., Yokota, I., Makita, H., Sato, S., Hirai, T., and Nishimura, M. (2021). Parenchymal destruction in asthma: Fixed airflow obstruction and lung function trajectory. J. Allergy Clin. Immunol.","DOI":"10.1016\/j.jaci.2021.07.042"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1378\/chest.07-0713","article-title":"Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: Insights from the TENOR study","volume":"132","author":"Lee","year":"2007","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2222.2012.03983.x","article-title":"Pathogenesis of severe asthma","volume":"42","author":"Poon","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"00309","DOI":"10.1183\/23120541.00309-2020","article-title":"Identification and treatment of T2-low asthma in the era of biologics","volume":"7","author":"Kyriakopoulos","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zaihra, T., Walsh, C.J., Ahmed, S., Fugere, C., Hamid, Q.A., Olivenstein, R., Martin, J.G., and Benedetti, A. (2016). Phenotyping of difficult asthma using longitudinal physiological and biomarker measurements reveals significant differences in stability between clusters. BMC Pulm. Med., 16.","DOI":"10.1186\/s12890-016-0232-2"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200905-0695OC","article-title":"Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma","volume":"181","author":"Dweik","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: The evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.13966","article-title":"Different endotypes and phenotypes drive the heterogeneity in severe asthma","volume":"75","author":"McDowell","year":"2020","journal-title":"Allergy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and Difficult-to-Treat Asthma in Adults","volume":"377","author":"Israel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cea.13302","article-title":"Fixed airflow obstruction relates to eosinophil activation in asthmatics","volume":"49","author":"Mogensen","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaci.2013.04.050","article-title":"Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids","volume":"132","author":"Kanemitsu","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1183\/09031936.00135907","article-title":"Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma","volume":"32","author":"Sterk","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mogensen, I., Jacinto, T., Alving, K., Fonseca, J.A., Janson, C., and Malinovschi, A. (2020). Inflammatory patterns in fixed airflow obstruction are dependent on the presence of asthma. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243109"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cea.13714","article-title":"Asthma and fixed airflow obstruction: Long-term trajectories suggest distinct endotypes","volume":"51","author":"Smith","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: Assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","article-title":"Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8","volume":"119","author":"Gibson","year":"2001","journal-title":"Chest"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Cooper, P.R., Mesaros, A.C., Zhang, J., Christmas, P., Stark, C.M., Douaidy, K., Mittelman, M.A., Soberman, R.J., Blair, I.A., and Panettieri, R.A. (2010). 20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010235"},{"key":"ref_47","first-page":"9868704","article-title":"Risk Factors Associated with Irreversible Airway Obstruction in Asthma: A Systematic Review and Meta-Analysis","volume":"2016","author":"Zhang","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.anai.2017.10.004","article-title":"Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma","volume":"120","author":"Bennett","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"00336","DOI":"10.1183\/23120541.00336-2020","article-title":"Higher body mass index is associated with increased lung stiffness and less airway obstruction in individuals with asthma and fixed airflow obstruction","volume":"7","author":"Rutting","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaci.2015.08.050","article-title":"Early growth characteristics and the risk of reduced lung function and asthma: A meta-analysis of 25,000 children","volume":"137","author":"Arshad","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ppul.24625","article-title":"Risk factors for fixed airflow obstruction in children and adolescents with asthma: 4-Year follow-up","volume":"55","author":"Sousa","year":"2020","journal-title":"Pediatric Pulmonol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.rmed.2015.09.009","article-title":"Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype","volume":"109","author":"Konstantellou","year":"2015","journal-title":"Respir. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jaci.2010.01.003","article-title":"Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up","volume":"125","author":"Contoli","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2009.09.047","article-title":"The irreversible component of persistent asthma","volume":"124","author":"Pascual","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/02770903.2014.895012","article-title":"Fixed airflow obstruction in asthma: A descriptive study of patient profiles and effect on treatment responses","volume":"51","author":"Tashkin","year":"2014","journal-title":"J. Asthma"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1365-2222.2009.03307.x","article-title":"Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus","volume":"39","author":"Skevaki","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000099463","article-title":"Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium","volume":"143","author":"Persdotter","year":"2007","journal-title":"Int. Arch Allergy Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaip.2016.02.014","article-title":"Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide\/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma","volume":"4","author":"Tashkin","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"00117","DOI":"10.1183\/23120541.00117-2021","article-title":"Airway smooth muscle cells from severe asthma patients with fixed airflow obstruction are responsive to steroid and bronchodilator treatment in vitro","volume":"7","author":"Rutting","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.rmed.2017.08.013","article-title":"The effect of umeclidinium on lung function and symptoms in patients with fixed airflow obstruction and reversibility to salbutamol: A randomised, 3-phase study","volume":"131","author":"Lee","year":"2017","journal-title":"Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40265-014-0250-4","article-title":"Asthma therapy and its effect on airway remodelling","volume":"74","author":"Berair","year":"2014","journal-title":"Drugs"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/resp.13375","article-title":"Bronchodilator responsiveness as a predictor of success for bronchial thermoplasty","volume":"24","author":"Langton","year":"2019","journal-title":"Respirology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1152\/japplphysiol.91356.2008","article-title":"Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity","volume":"108","author":"Behazin","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17476348.2018.1506331","article-title":"The effect of obesity on lung function","volume":"12","author":"Dixon","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaip.2017.07.010","article-title":"Overweight, Obesity, and Lung Function in Children and Adults\u2014A Meta-analysis","volume":"6","author":"Forno","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MCP.0000000000000226","article-title":"Asthma and obesity: Is weight reduction the key to achieve asthma control?","volume":"22","author":"Ulrik","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1164\/rccm.200510-1589OC","article-title":"Effects of smoking cessation on lung function and airway inflammation in smokers with asthma","volume":"174","author":"Chaudhuri","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.athoracsur.2019.08.075","article-title":"Outcomes of an Intensive, Preoperative Smoking Cessation Program","volume":"109","author":"Fay","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_71","first-page":"A4683","article-title":"Effect of Mepolizumab on Exacerbations in Asthma Patients with Features Common in COPD, in B101","volume":"195","author":"Albers","year":"2017","journal-title":"Adv. Asthma"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2147\/COPD.S294333","article-title":"Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO","volume":"16","author":"Pavord","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): A randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2019.10.006","article-title":"Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma","volume":"124","author":"Chipps","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Pelaia, C., Calabrese, C., Terracciano, R., de Blasio, F., Vatrella, A., and Pelaia, G. (2018). Omalizumab, the first available antibody for biological treatment of severe asthma: More than a decade of real-life effectiveness. Ther. Adv. Respir. Dis., 12.","DOI":"10.1177\/1753466618810192"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaip.2021.08.006","article-title":"Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA","volume":"10","author":"Hanania","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"00204-2019","DOI":"10.1183\/23120541.00204-2019","article-title":"Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma","volume":"6","author":"Castro","year":"2020","journal-title":"ERJ Open Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/crj.13433","article-title":"IL-25R(+) circulating fibrocytes are increased in asthma and correlate with fixed airflow limitation","volume":"15","author":"Yao","year":"2021","journal-title":"Clin. Respir. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imr.12558","article-title":"IL-25 in allergic inflammation","volume":"278","author":"Xu","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_81","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (2021, November 08). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2021 Report) 2020. Available online: https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: Toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.2147\/COPD.S114964","article-title":"Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome","volume":"11","author":"Lee","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.jaip.2018.01.035","article-title":"Use of ICS\/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma","volume":"6","author":"Su","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5414\/CP203382","article-title":"Effect of triple therapy in patients with asthma-COPD overlap","volume":"57","author":"Ishiura","year":"2019","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pupt.2012.09.007","article-title":"Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes","volume":"26","author":"Yoshida","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): A randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/3\/333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:25:47Z","timestamp":1760135147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/3\/333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":88,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["jpm12030333"],"URL":"https:\/\/doi.org\/10.3390\/jpm12030333","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]}}}